Los Angeles Clinical Trials   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Burbank CA United States (1999)

Organization Overview

First Clinical Trial
2013
NCT01898169
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

LA Clinical Trials | Los Angeles Clinical Trials

Active Ingredients

Drugs in Phase 4 Trials (1)

varenicline (chantix) (1 trial)

Drugs in Phase 2 Trials (1)

cytisine (1 trial)

Drugs in Phase 1 Trials (1)

nicotine (nicorette) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Substance Withdrawal Syndrome (Phase 4)

Tobacco Use Disorder (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 3